Clinical Trial Update: Safety and Effectiveness of Subconjunctival Injection of Bevacizumab in the Treatment of Corneal Neovasculization [NA]

View source ↗

Summary

A completed clinical trial evaluated the safety and effectiveness of subconjunctival bevacizumab for treating corneal neovascularization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Neovascularization
• Herpetic Keratopathy
• Lipid Keratopathy
• Rosacea

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Lipid Keratopathy, Penetrating Keratoplasty | NA | Status: COMPLETED